Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega
Alkermes plc (NASDAQ: ALKS) reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56</
Earnings Scheduled For July 26, 2023
Companies Reporting Before The Bell
• GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue of $8.97 billion.
• Stellantis (NYSE:STLA) is likely to report earnings for its first quarter.
Earnings Preview: Alkermes
Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2023-07-26. Here’s what investors need…
Sarissa Issues Presentation Highlighting The Need For Shareholder Representation On The Alkermes Board
Sarissa believes Chairman and CEO Richard Pops wants to prevent accountability and oversight that would come from Sarissa representation on the Alkermes boardSarissa believes Chairman and CEO Richard Pops will never run
Where Alkermes Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on Alkermes (NASDAQ:ALKS) stock. These analysts are…
Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements
Alkermes plc (NASDAQ:ALKS) increased its FY23 outlook by $425 million to reflect a final award the company received from…
Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences
Alkermes plc (NASDAQ:ALKS) today announced the presentation of research related to its psychiatry portfolio—which includes LYBALVI® (olanzapine and samidorphan) and
Alkermes Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Alkermes (NASDAQ:ALKS) reported Q1 sales of $287.60 million. Earnings fell to a loss of $41.84…
Analyst Expectations for Alkermes’s Future
Over the past 3 months, 5 analysts have published their opinion on Alkermes (NASDAQ:ALKS) stock. These analysts are…
The Latest Analyst Ratings for Alkermes
Alkermes (NASDAQ:ALKS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…